The evidence required for submissions to health authorities and decision makers continues to evolve, requiring increasingly sophisticated methods to demonstrate value. Meeting the evidence demands for reimbursement and optimal pricing requires thorough analyses of the current research conducted to date to identify key value drivers, data gaps, and comparative effects across therapies, along with a team of experts that can integrate findings into the overall value proposition. Evidera’s expert team of scientists, modelers and statisticians has developed hundreds of simulations, statistical models, and literature reviews to support reimbursement, market access, and internal decision making in all major therapeutic indications and across all major markets.
The healthcare landscape is changing rapidly and the needs and requirements of key stakeholders (e.g., payers, providers, manufacturers) are evolving along with it. Evidera’s experts have extensive experience working with these stakeholders to select the method and approach that best addresses each research question. We are able to maximize the impact of traditional methods, but are also adept at developing and deploying new solutions and approaches to better meet the needs of decision makers. We are passionate about advancing methodology in modeling and evidence synthesis, and have a history of innovation. Our team of experts introduced discrete event simulation (DES) to the healthcare field, and continue to work toward new solutions. A few of our latest cutting-edge methodologies and products are as follows: